Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmo Bio Co's Other Operating Expense for the
six
months ended in Dec. 2025 was 円1,769 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was 円3,359 Mil.
Cosmo Bio Co's quarterly Other Operating Expense
declined
from Dec. 2024 (円1,621 Mil) to Jun. 2025 (円1,590 Mil) but then
increased
from Jun. 2025 (円1,590 Mil) to Dec. 2025 (円1,769 Mil).
Cosmo Bio Co's annual Other Operating Expense
increased
from Dec. 2023 (円2,729 Mil) to Dec. 2024 (円3,010 Mil) and
increased
from Dec. 2024 (円3,010 Mil) to Dec. 2025 (円3,359 Mil).
Cosmo Bio Co Other Operating Expense Related Terms
Cosmo Bio Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Cosmo Bio Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円3,359 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of 円3,359 Mil mean?
Cosmo Bio Co (TSE:3386) has a Other Operating Expense of 円3,359 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Cosmo Bio Co and its competitors.
Is Cosmo Bio Co's Other Operating Expense too high?
Cosmo Bio Co's current Other Operating Expense is 円3,359 Mil. Overall, Cosmo Bio Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's Other Operating Expense compare to TMO and DHR?
Cosmo Bio Co's Other Operating Expense of 円3,359 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Diagnostics & Research company?
A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cosmo Bio Co and its competitors. Cosmo Bio Co's current Other Operating Expense is 円3,359 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,251.85, compared to a current price of 円1,244.00 — trading 0.6% below its estimated fair value. The current Other Operating Expense is 円3,359 Mil. Cosmo Bio Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Other Operating Expense is 円3,359 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be undervalued.
The current stock price of 円1,244.00 is trading 0.6% below its estimated GF Value™ of 円1,251.85.
GuruFocus considers Cosmo Bio Co to be Fairly Valued.
Key valuation signals for TSE:3386:
Other Operating Expense: 円3,359 Mil
GF Value™: 円1,251.85 vs. price of 円1,244.00 (0.6% below fair value)
No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
70GF Score
Get the complete analysis for TSE:3386
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3386 has been successfully added to your 
